Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Breath Testing in Enriching the Likelihood of Response to Rifaximin in Patients With Diarrhea IBS

NCT03729271 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03729271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03729271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Breath Testing in Enriching the Likelihood of Response to Rifaximin in Patients With Diarrhea IBS
Lead sponsor
University of Michigan
Phase
Phase 4
Overall status
Completed
Start date
January 9, 2020
Completion date
January 1, 2026
Enrollment
148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome, irritable bowel syndrome with diarrhea